Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baird Medical Investment HoldingsBDMD +0.43%17 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 688 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks worse than 145348.69% on this metric.
During the past 12 months, Baird Medical Investment Holdings's average EBITDA Per Share Growth Rate was -346.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Baird Medical Investment Holdings was 9.30% per year. The lowest was 9.30% per year. And the median was 9.30% per year.
Baird Medical Investment Holdings (NAS:BDMD) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Baird Medical Investment Holdings 3-Year EBITDA Growth Rate Related Terms
BDMD vs TANAF, NSYS, ARAY: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Baird Medical Investment Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's 3-Year EBITDA Growth Rate falls into.
Baird Medical Investment Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Baird Medical Investment Holdings (BDMD) has a 3-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Baird Medical Investment Holdings and its competitors. Over the past decade, Baird Medical Investment Holdings' 3-Year EBITDA Growth Rate has ranged from 9.30 to 9.30. According to the industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 688 companies in the Medical Devices & Instruments industry.
Is Baird Medical Investment Holdings' 3-Year EBITDA Growth Rate too high?
Baird Medical Investment Holdings' current 3-Year EBITDA Growth Rate is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.30 to a high of 9.30. Based on the distribution chart, Baird Medical Investment Holdings ranks #999999 out of 688 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' 3-Year EBITDA Growth Rate compare to TANAF and NSYS?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #999999 out of 688 companies for 3-Year EBITDA Growth Rate. This places Baird Medical Investment Holdings in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. Historically, Baird Medical Investment Holdings' own 3-Year EBITDA Growth Rate has ranged from 9.30 to 9.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.90, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Baird Medical Investment Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current 3-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
